Michael E. Meyers
Michael E. Meyers
Stop FollowingMichael E. Meyers
ABOUT
Michael is the Chief Executive Officer & CIO of Arcoda Capital Management LP, a Registered Investment Advisor that manages global healthcare long-short funds.
Michael has enjoyed a 20 year career in healthcare asset management, investment banking and in the operating environment. Prior to moving to the buyside in 1999, Michael was Director, Biotechnology and Pharmaceutical Investment Banking at Merrill Lynch & Co. in New York. Arcoda’s investment team includes Managing Director, Scott Gottlieb, M.D., a former Deputy Commissioner of the U.S. Food and Drug Administration and a Senior Advisor to the Centers for Medicare & Medicaid Services, among other team members.
Michael holds an M.P.H. in ...More Health Policy and Management from Columbia University and an A.B. in Biology from Brandeis University in Massachusetts.
Michael has enjoyed a 20 year career in healthcare asset management, investment banking and in the operating environment. Prior to moving to the buyside in 1999, Michael was Director, Biotechnology and Pharmaceutical Investment Banking at Merrill Lynch & Co. in New York. Arcoda’s investment team includes Managing Director, Scott Gottlieb, M.D., a former Deputy Commissioner of the U.S. Food and Drug Administration and a Senior Advisor to the Centers for Medicare & Medicaid Services, among other team members.
Michael holds an M.P.H. in ...More Health Policy and Management from Columbia University and an A.B. in Biology from Brandeis University in Massachusetts.
SNAPSHOT
This area is reserved for Michael E. Meyers':
- Self-description
- Trading frequency
- Interests
Users can update their snapshots by editing their profiles via Settings.
COMPANY
Currently, there is no company profile for Michael E. Meyers.
BLOG
Currently, there are no blog details for Michael E. Meyers.
Book
Currently, there are no book details for Michael E. Meyers.
Latest Comments
more »
- Ivy2,The investment opportu... on Intellipharmaceutics: A Deep Value Opportunity ...
- I wanted to provide a brief... on Intellipharmaceutics: A Deep Value Opportunity ...
- dldavide,Thank you for your... on Intellipharmaceutics: A Deep Value Opportunity ...
- Thank you Biff on High Conviction: A Therapeutics Firm With a Fir...
- Re-read the article. We are... on High Conviction: A Therapeutics Firm With a Fir...
Latest comments on Michael E.'s Articles
- tonyengel69 on Intellipharmaceutics: A Deep Value Opportunity ...
- sapaburu on Intellipharmaceutics: A Deep Value Opportunity ...
- Michael E. Meyers on Intellipharmaceutics: A Deep Value Opportunity ...
- IVY2 on Intellipharmaceutics: A Deep Value Opportunity ...
- Michael E. Meyers on Intellipharmaceutics: A Deep Value Opportunity ...
LATEST ARTICLES & INSTAPOSTS
more »
